semaglutide ckd approval just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in FDA Approves Ozempic for Kidney

Because we just don't know yet exactly what the long-term outcomes are." Deidre McIntosh, MD, Ob/Gyn, Cleveland Clinic It's also worth noting that GLP-1 medications might interfere with oral contraceptive absorption

PHRC is unique because of the specific focus on pelvic floor disorders and the leadership at our company

These receptors determine what each peptide does, or doesn't do

The data will be available permanently after research completion and approval of product and product use in both EU and USA

Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study

PlexusDx works with you to find the sweet spot between efficacy and tolerability